Clinical Trial Update: Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose Combination [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting long-term efficacy and safety data for the aclidinium bromide/formoterol fumarate fixed-dose combination in chronic obstructive p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Duaklir Breezhaler (aclidinium bromide/formoterol fumarate)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Status: COMPLETED | Results posted: 2017-02-15